Irsogladine maleate

DRUG4 trials

Sponsors

Faculty of Medicine, Kagawa University, Boryung Pharmaceutical Co., Ltd, Lee's Pharmaceutical Limited

Conditions

Gastric UlcerNSAIDs-associated Intestinal Mucosal InjuryPeptic Ulceroral lichen planus

Phase 1

The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers

CompletedNCT02581696

Boryung Pharmaceutical Co., LtdPeptic Ulcer

Start: 2015-08-31End: 2015-11-30Updated: 2017-02-06

A Study to Compare the Pharmacokinetics of Lafutidine and Irsogladine Maleate Tablet

CompletedNCT02759224

Boryung Pharmaceutical Co., LtdGastric Ulcer

Start: 2016-04-15End: 2016-12-29Updated: 2017-02-07

Phase 4

Therapeutic Effect of Isogladine Maleate on Small Intestinal Mucosal Injury Associated With NSAIDS in Population

Lee's Pharmaceutical LimitedNSAIDs-associated Intestinal Mucosal Injury

Start: 2022-04-30End: 2023-04-30Target: 100Updated: 2022-04-04

Unknown Phase

Evaluation for efficacy and safety of Irsogladine maleate for oral lichen planus

Active, not recruitingJPRN-UMIN000008735

Faculty of Medicine, Kagawa Universityoral lichen planus

Start: 2012-06-12Target: 40Updated: 2025-07-18